BACKGROUND:
In co-infected individuals two or more HIV-1 strains established close to
the time of PHI, whereas in super-infection a second strain established
several months to years after PHI. Does this lead over time to differential
replication of the strains?
PATIENTS AND METHODS:
Three intravenous drug users (IVDUs) co-infected with B subtype and CRF-11,
two IVDUs initially infected with B subtype and lateron infected with
CRF-11. Population sequencing of reverse transcriptase, protease and gag
p24, subtype -specific nested PCR with a first generic PCR
(amplification of a 1397 bp gag/pol fragment –1872–3251 in ref to
HXB2–) followed by a nested B and CRF-11-specific PCR. Population sequencing
of the B and CRF-11 amplicons.
RESULTS:
Using subtype-specific PCR and limiting dilutions with constant amount of
the heterologous subtype (250000 HIV-1 RNA copies) and decreasing amount of
the homologous subtype (1000–10 HIV-1 RNA copies), the detection limit was
<10 copies of the homologous subtype in 250000 copies of the heterologous
subtype, and there was no amplification of the heterologous subtype in
presence of 250000 copies. In the three co-infected patients, both CRF-11
and B subtypes were detected in plasma and proviral DNA analysed over a
follow-up of 14, 20 and 24 months, respectively. Two of the three patients
had viraemia >400000 copies/ml during the follow-up. A genetic tree based on
sequences of the B-specific amplicons of 10 IVDUs infected with B subtypes
and of the three coinfected patients indicated that two over three
coinfected patients were infected with different B strains.
The two super-infected patients, initially infected by a B
subtype, can be referred as LTNPs since they control their viraemia without
treatment to <50 copies/ml and had <500 CD4/mm3 for, respectively, 3 and 5
years before becoming infected with CRF-11. In these two patients,
super-infection with CRF-11 was associated with high viraemia, steep drop in
CD4 and an acute retroviral syndrome (ARS). CFR-11 was the only detectable
subtype in the plasma at the time of superinfection and later on in
follow-up samples. Both subtypes were detectable in proviral DNA after the
superinfection and during the follow-up. Genetic trees performed on B and
CRF-11 amplicons indicate that the patients were initially infected with
different B strains, whereas results for CRF-11 were inconclusive due to the
high degree of homogeneity of sequences of the CRF-11 amplicons for both the
super-infected IVDUs and other IVDUs infected with CRF-11 only.
CONCLUSIONS:
In co-infected patients both HIV-1subtypes persist during the follow-up,
whereas in superinfected patients, despite massive immune activation
associated with the ARS at the time of super-infection, only the second
strain was detectable in plasma.